Published in Int J Geriatr Psychiatry on February 01, 2005
Sertraline for the treatment of depression in Alzheimer disease. Am J Geriatr Psychiatry (2010) 1.60
Neuropsychiatric symptoms in MCI subtypes: the importance of executive dysfunction. Int J Geriatr Psychiatry (2010) 1.13
Diagnosing depression in Alzheimer disease with the national institute of mental health provisional criteria. Am J Geriatr Psychiatry (2008) 0.96
Cognitive outcomes after sertaline treatment in patients with depression of Alzheimer disease. Am J Geriatr Psychiatry (2012) 0.93
Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)? Int J Geriatr Psychiatry (2011) 0.90
How do the PHQ-2, the PHQ-9 perform in aging services clients with cognitive impairment? Int J Geriatr Psychiatry (2010) 0.85
Psychiatric manifestations of neurologic disease: where are we headed? Dialogues Clin Neurosci (2007) 0.82
Sertraline for the treatment of depression in Alzheimer disease: genetic influences. J Geriatr Psychiatry Neurol (2011) 0.78
Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med (2006) 10.89
A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement (2009) 10.21
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain (2011) 9.90
High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial. JAMA (2008) 7.35
Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease. N Engl J Med (2014) 6.50
A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimers Dement (2008) 6.39
Developing a national strategy to prevent dementia: Leon Thal Symposium 2009. Alzheimers Dement (2010) 4.85
Mood disorders in the medically ill: scientific review and recommendations. Biol Psychiatry (2005) 4.81
Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial. JAMA (2009) 4.02
Antidepressant pharmacotherapy in the treatment of depression in the very old: a randomized, placebo-controlled trial. Am J Psychiatry (2004) 3.84
Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey. Am J Epidemiol (2003) 3.79
Atlas-based whole brain white matter analysis using large deformation diffeomorphic metric mapping: application to normal elderly and Alzheimer's disease participants. Neuroimage (2009) 3.74
Cardiovascular risk of celecoxib in 6 randomized placebo-controlled trials: the cross trial safety analysis. Circulation (2008) 3.63
Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial. Am J Psychiatry (2008) 3.48
Outcomes of minor and subsyndromal depression among elderly patients in primary care settings. Ann Intern Med (2006) 3.27
Position statement of the American Association for Geriatric Psychiatry regarding principles of care for patients with dementia resulting from Alzheimer disease. Am J Geriatr Psychiatry (2006) 3.22
Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am J Epidemiol (2005) 3.10
The relationship between a dementia diagnosis, chronic illness, medicare expenditures, and hospital use. J Am Geriatr Soc (2004) 2.89
Cognitive function over time in the Alzheimer's Disease Anti-inflammatory Prevention Trial (ADAPT): results of a randomized, controlled trial of naproxen and celecoxib. Arch Neurol (2008) 2.86
Mania during treatment of chronic hepatitis C with pegylated interferon and ribavirin. Am J Psychiatry (2004) 2.82
Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol (2012) 2.75
Epidemiology of adult psychiatric visits to US emergency departments. Acad Emerg Med (2004) 2.72
Antihypertensive medication use and incident Alzheimer disease: the Cache County Study. Arch Neurol (2006) 2.71
Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psychiatry (2003) 2.70
Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift. Neuron (2011) 2.67
Systematic review of psychological approaches to the management of neuropsychiatric symptoms of dementia. Am J Psychiatry (2005) 2.61
Risk of mortality among individual antipsychotics in patients with dementia. Am J Psychiatry (2011) 2.59
Meta-analysis of Alzheimer's disease risk with obesity, diabetes, and related disorders. Biol Psychiatry (2009) 2.57
Reducing suicidal ideation and depression in older primary care patients: 24-month outcomes of the PROSPECT study. Am J Psychiatry (2009) 2.56
Psychopathology in patients with degenerative cerebellar diseases: a comparison to Huntington's disease. Am J Psychiatry (2002) 2.52
Psychiatric and neuropsychiatric adverse events associated with deep brain stimulation: A meta-analysis of ten years' experience. Mov Disord (2007) 2.47
Point and 5-year period prevalence of neuropsychiatric symptoms in dementia: the Cache County Study. Int J Geriatr Psychiatry (2008) 2.32
Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry (2006) 2.29
Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. Am J Geriatr Psychiatry (2006) 2.26
Mild behavioral impairment and risk of dementia: a prospective cohort study of 358 patients. J Clin Psychiatry (2009) 2.16
Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD. Am J Psychiatry (2011) 2.15
Novel late-onset Alzheimer disease loci variants associate with brain gene expression. Neurology (2012) 2.08
Remission in depressed geriatric primary care patients: a report from the PROSPECT study. Am J Psychiatry (2005) 2.04
Agoraphobia in adults: incidence and longitudinal relationship with panic. Br J Psychiatry (2006) 2.01
The Maryland Assisted Living Study: prevalence, recognition, and treatment of dementia and other psychiatric disorders in the assisted living population of central Maryland. J Am Geriatr Soc (2004) 2.01
Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. J Am Geriatr Soc (2004) 2.00
Designing drug trials for Alzheimer's disease: what we have learned from the release of the phase III antibody trials: a report from the EU/US/CTAD Task Force. Alzheimers Dement (2013) 1.98
Efficacy and adverse effects of cholinesterase inhibitors and memantine in vascular dementia: a meta-analysis of randomised controlled trials. Lancet Neurol (2007) 1.97
Serum ceramides increase the risk of Alzheimer disease: the Women's Health and Aging Study II. Neurology (2012) 1.91
Extended results of the Alzheimer's disease anti-inflammatory prevention trial. Alzheimers Dement (2011) 1.87
Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol (2009) 1.86
Vascular risk factors for incident Alzheimer disease and vascular dementia: the Cache County study. Alzheimer Dis Assoc Disord (2006) 1.85
Using a Bayesian latent growth curve model to identify trajectories of positive affect and negative events following myocardial infarction. Biostatistics (2005) 1.84
Caregiver burden in Alzheimer disease: cross-sectional and longitudinal patient correlates. Am J Geriatr Psychiatry (2010) 1.83
Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia: the Cache County Dementia Progression study. Am J Geriatr Psychiatry (2011) 1.83
The association of neuropsychiatric symptoms in MCI with incident dementia and Alzheimer disease. Am J Geriatr Psychiatry (2013) 1.80
American Psychiatric Association practice guideline for the treatment of patients with Alzheimer's disease and other dementias. Second edition. Am J Psychiatry (2007) 1.79
Statin use and the risk of incident dementia: the Cardiovascular Health Study. Arch Neurol (2005) 1.76
The impact of anemia on energy and physical functioning in individuals with AIDS. Arch Intern Med (2005) 1.75
Personal characteristics of older primary care patients who provide a buccal swab for apolipoprotein E testing and banking of genetic material: the spectrum study. Community Genet (2004) 1.75
Nonpharmacologic management of behavioral symptoms in dementia. JAMA (2012) 1.75
Provisional diagnostic criteria for depression of Alzheimer disease. Am J Geriatr Psychiatry (2002) 1.75
Characteristics of established and proposed sporadic Creutzfeldt-Jakob disease variants. Arch Neurol (2009) 1.74
Greater risk of dementia when spouse has dementia? The Cache County study. J Am Geriatr Soc (2010) 1.73
Safety and efficacy of methylphenidate for apathy in Alzheimer's disease: a randomized, placebo-controlled trial. J Clin Psychiatry (2013) 1.73
Cost-benefit analysis of second-generation antipsychotics and placebo in a randomized trial of the treatment of psychosis and aggression in Alzheimer disease. Arch Gen Psychiatry (2007) 1.73
Recognition and treatment of depression in Parkinson's disease. J Geriatr Psychiatry Neurol (2003) 1.71
Metabolic changes associated with second-generation antipsychotic use in Alzheimer's disease patients: the CATIE-AD study. Am J Psychiatry (2009) 1.70
Single-dose azithromycin prevents trichiasis recurrence following surgery: randomized trial in Ethiopia. Arch Ophthalmol (2006) 1.69
Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology (2007) 1.68
Neuropsychiatric symptom patterns in hospice-eligible nursing home residents with advanced dementia. J Am Med Dir Assoc (2008) 1.67
Depression and HIV risk behaviors among patients in a sexually transmitted disease clinic. Am J Psychiatry (2004) 1.67
Neuropsychiatric symptoms as predictors of progression to severe Alzheimer's dementia and death: the Cache County Dementia Progression Study. Am J Psychiatry (2015) 1.65
The prevalence of psychiatric disorders in sexually transmitted disease clinic patients and their association with sexually transmitted disease risk. Sex Transm Dis (2004) 1.65
Cognitive function after 11.5 years of alcohol use: relation to alcohol use. Am J Epidemiol (2002) 1.64
Unmet needs of community-residing persons with dementia and their informal caregivers: findings from the maximizing independence at home study. J Am Geriatr Soc (2013) 1.63
Modifiable predictors of dementia in mild cognitive impairment: a systematic review and meta-analysis. Am J Psychiatry (2015) 1.62
Screening, assessment, and management of depression in VA primary care clinics. The Behavioral Health Laboratory. J Gen Intern Med (2006) 1.61
The spectrum of medical illness and medication use among residents of assisted living facilities in central Maryland. J Am Med Dir Assoc (2008) 1.61
A commentary on the proposed DSM revision regarding the classification of cognitive disorders. Am J Geriatr Psychiatry (2011) 1.61
Sertraline for the treatment of depression in Alzheimer disease. Am J Geriatr Psychiatry (2010) 1.60